Ariad Pharmaceuticals, Inc.

UEI
EVMMLCKBZS47
CAGE
6W6K6
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Founded
1993
Employees
1K-5K
Estimated annual revenue
$250M-$500M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Iclusig 15MG tablets. 36C25219F0494 Veterans Integrated Service Network 12 (VHA) $11,502
NDC 76189-0535-30 ponatinib 15MG 36C24919N0606 Veterans Integrated Service Network 9 (VHA) $23,004
Ponatinib 36C24919F0373 Veterans Integrated Service Network 9 (VHA) $11,502
Iclusig 36C25219F0450 Veterans Integrated Service Network 12 (VHA) $11,502
Ponatinib 45 MG 36C24519F0682 Veterans Integrated Service Network 5 (VHA) $0

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Ariad Pharmaceuticals, Inc. is a pharmaceutical company that provides cancer drugs to the federal government through the GSA Pharmaceuticals and Drugs schedule. As described on its website, Ariad combines innovative science from a leading American biopharmaceutical company with global assets from Japan's largest pharmaceutical company, and focuses on discovering and developing oncology treatments.

Through prime federal contract awards, Ariad has provided cancer drugs such as Iclusig (ponatinib) and Lenvima (lenvatinib) to the Department of Veterans Affairs. These delivery orders were made under the GSA Pharmaceuticals and Drugs schedule by various Veterans Health Administration Veterans Integrated Service Networks to supply veterans hospitals and medical centers. The contract awards were not set aside, and ranged in value from $11,502 to $23,004 per order. In one case, Ariad received a $19,900 delivery order to provide an express report on pharmacy ordering of Lenvima. In total over the past two years, Ariad has been awarded over $100,000 in federal contracts to supply critical oncology medications to veterans in need.

Quick answers

Is Ariad Pharmaceuticals, Inc. registered in SAM.gov?

Ariad Pharmaceuticals, Inc.'s SAM.gov registration expired on June 20, 2020.

Which contract vehicles does Ariad Pharmaceuticals, Inc. hold?

Ariad Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Ariad Pharmaceuticals, Inc.'s most recent federal award?

Ariad Pharmaceuticals, Inc.'s most recent federal contract award is Iclusig 15MG tablets (36C25219F0494), from Veterans Integrated Service Network 12 (VHA), on July 22, 2019.

On GovTribe

See Ariad Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors